These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 2072661

  • 1. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
    DePalatis LR, Johnson KA, Kaplan DA.
    Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661
    [Abstract] [Full Text] [Related]

  • 2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 3. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.
    Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Miller LS, Houchens D, Cheng R, Kaplan D, Goeckeler W.
    Cancer Res; 1991 Jun 01; 51(11):2889-96. PubMed ID: 1851665
    [Abstract] [Full Text] [Related]

  • 5. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G, Booth BJ, Batra SK, Colcher D.
    Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640
    [Abstract] [Full Text] [Related]

  • 6. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 7. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Schlom J.
    Cancer Res; 1992 Jun 15; 52(12):3402-8. PubMed ID: 1596900
    [Abstract] [Full Text] [Related]

  • 8. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [Abstract] [Full Text] [Related]

  • 9. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J.
    Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194
    [Abstract] [Full Text] [Related]

  • 10. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A, Simpson JF, Thor A, Schlom J.
    Cancer Res; 1990 Feb 15; 50(4):1291-8. PubMed ID: 2297774
    [Abstract] [Full Text] [Related]

  • 11. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
    Kitamura K, Takahashi T, Kotani T, Miyagaki T, Yamaoka N, Tsurumi H, Noguchi A, Yamaguchi T.
    Cancer Res; 1992 Nov 15; 52(22):6323-8. PubMed ID: 1423277
    [Abstract] [Full Text] [Related]

  • 12. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM, Gold DV, Aninipot R, Vagg R, Ballance C, Newman ES, Ostella F, Hansen HJ, Goldenberg DM.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [Abstract] [Full Text] [Related]

  • 13. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
    Ong GL, Mattes MJ.
    Cancer Res; 1989 Aug 01; 49(15):4264-73. PubMed ID: 2743313
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
    Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF.
    Clin Cancer Res; 2005 Nov 15; 11(22):8180-5. PubMed ID: 16299250
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
    Schlom J, Eggensperger D, Colcher D, Molinolo A, Houchens D, Miller LS, Hinkle G, Siler K.
    Cancer Res; 1992 Mar 01; 52(5):1067-72. PubMed ID: 1310638
    [Abstract] [Full Text] [Related]

  • 16. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N, Saga T, Sakahara H, Yao Z, Nakamoto Y, Zhang M, Kuroki M, Matsuoka Y, Iida Y, Konishi J.
    J Nucl Med; 1999 Apr 01; 40(4):685-92. PubMed ID: 10210230
    [Abstract] [Full Text] [Related]

  • 17. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M, Hitchcock CL, Molinolo A, Milenic DE, Colcher D, Martin EW, Hinkle GH, Schlom J.
    Anticancer Res; 1995 Apr 01; 15(3):975-84. PubMed ID: 7645989
    [Abstract] [Full Text] [Related]

  • 18. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF, El-Emir E, Boxer GM, Qureshi U, Dearling JL, Robson MP, Begent RH, Trott KR, Pedley RB.
    Clin Cancer Res; 2008 May 01; 14(9):2639-46. PubMed ID: 18451227
    [Abstract] [Full Text] [Related]

  • 19. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G, Bamias A, Krausz T, Epenetos AA.
    Cancer Res; 1991 Jun 15; 51(12):3251-6. PubMed ID: 2040000
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.
    Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5857s-5863s. PubMed ID: 7493360
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.